Search   
MSDS  : 5-beta-Cholan-24-oic acid, 3-alpha,7-alpha-dihydroxy-
CAS  : 474-25-9
SYNONYMS  : * Anthropodeoxycholic acid * Anthropodesoxycholic acid * Anthropododesoxycholic acid * CDC * Chendol * Chenic acid * Chenodeoxycholic acid * Chenodesoxycholic acid * Chenodesoxycholsaeure * Chenodiol * Cholan-24-oic acid, 3,7-dihydroxy-, (3-alpha,5-beta,7-alpha)- * 3-alpha,7-alpha-Dihydroxycholanic acid * 3-alpha,7-alpha-Dihydroxy-5-beta-cholan-24-oic acid * 3-alpha,7-alpha-Dihydroxycholansaeure * Gallodesoxycholic acid * 7-alpha-Hydroxylithocholic acid
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : FZ1980000
CHEMICAL NAME : 5-beta-Cholan-24-oic acid, 3-alpha,7-alpha-dihydroxy-
CAS REGISTRY NUMBER : 474-25-9
LAST UPDATED : 199806
DATA ITEMS CITED : 30
MOLECULAR FORMULA : C24-H40-O4
MOLECULAR WEIGHT : 392.64
WISWESSER LINE NOTATION : L E5 B666TJ A1 E1 FY1&2VQ KQ OQ
COMPOUND DESCRIPTOR : Tumorigen
Drug
Mutagen
Reproductive Effector
Human
SYNONYMS/TRADE NAMES :
* Anthropodeoxycholic acid
* Anthropodesoxycholic acid
* Anthropododesoxycholic acid
* CDC
* Chendol
* Chenic acid
* Chenodeoxycholic acid
* Chenodesoxycholic acid
* Chenodesoxycholsaeure
* Chenodiol
* Cholan-24-oic acid, 3,7-dihydroxy-, (3-alpha,5-beta,7-alpha)-
* 3-alpha,7-alpha-Dihydroxycholanic acid
* 3-alpha,7-alpha-Dihydroxy-5-beta-cholan-24-oic acid
* 3-alpha,7-alpha-Dihydroxycholansaeure
* Gallodesoxycholic acid
* 7-alpha-Hydroxylithocholic acid

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 4 gm/kg
TOXIC EFFECTS :
Behavioral - changes in motor activity (specific assay)
Lungs, Thorax, or Respiration - dyspnea
Gastrointestinal - hypermotility, diarrhea
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 15,915,1978

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 105 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Gastrointestinal - other changes
Skin and Appendages - hair
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 15,915,1978

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >4 gm/kg
TOXIC EFFECTS :
Blood - changes in spleen
Skin and Appendages - hair
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 11,2499,1977

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 106 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Behavioral - convulsions or effect on seizure threshold
Behavioral - ataxia
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 15,915,1978

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: -,397,1990

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >2 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: -,464,1995

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 86 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Gastrointestinal - hypermotility, diarrhea
Gastrointestinal - other changes
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 15,915,1978

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >4 gm/kg
TOXIC EFFECTS :
Gastrointestinal - ulceration or bleeding from small intestine
Skin and Appendages - hair
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 11,2499,1977

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 100 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 20,323,1970

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
YAKUD5 Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka
Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959-
Volume(issue)/page/year: 24,1157,1982

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : >1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: -,397,1990

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - hamster
DOSE/DURATION : 500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: -,464,1995

** OTHER MULTIPLE DOSE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 3750 mg/kg/30D-C
TOXIC EFFECTS :
Endocrine - changes in adrenal weight
Related to Chronic Data - changes in prostate weight
Related to Chronic Data - changes in testicular weight
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 15,961,1978

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 45500 mg/kg/26W-C
TOXIC EFFECTS :
Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol)
Biochemical - Enzyme inhibition, induction, or change in blood or tissue
levels - phosphatases
Related to Chronic Data - death
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 15,1005,1978

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 18200 mg/kg/52W-C
TOXIC EFFECTS :
Liver - other changes
Liver - changes in liver weight
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 15,975,1978

** TUMORIGENIC DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - woman
DOSE/DURATION : 24 gm/kg/5Y-C
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria
Liver - tumors
REFERENCE :
CLONEA Clinics in Oncology. (W.B. Saunders Co., W. Washington Sq.,
Philadelphia, PA 19105) V.1- 1982- Volume(issue)/page/year: 7,245,1981

** REPRODUCTIVE DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 100 mg/kg
SEX/DURATION : male 1 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death
REFERENCE :
NTIS** National Technical Information Service. (Springfield, VA 22161)
Formerly U.S. Clearinghouse for Scientific & Technical Information.
Volume(issue)/page/year: PB81-127581

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 1785 mg/kg
SEX/DURATION : female 4-20 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - hepatobiliary system
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans
Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4-
1898- Volume(issue)/page/year: 246,149,1980

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 550 mg/kg
SEX/DURATION : female 7-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
resorbed implants per total number of implants)
Reproductive - Effects on Embryo or Fetus - fetal death
Reproductive - Effects on Newborn - physical
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 16,51,1978

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 1375 mg/kg
SEX/DURATION : female 7-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 16,51,1978

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 3480 mg/kg
SEX/DURATION : female 15-22 day(s) after conception
lactating female 21 day(s) post-birth
TOXIC EFFECTS :
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight
gain)
REFERENCE :
NTIS** National Technical Information Service. (Springfield, VA 22161)
Formerly U.S. Clearinghouse for Scientific & Technical Information.
Volume(issue)/page/year: PB81-127581

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Primate - monkey
DOSE : 14820 mg/kg
SEX/DURATION : female 31 week(s) pre-mating
female 1-24 week(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - hepatobiliary system
REFERENCE :
ANSUA5 Annals of Surgery. (Lippincott/Harper, Journal Fulfillment Dept.,
2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1885-
Volume(issue)/page/year: 184,490,1976

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Primate - monkey
DOSE : 1500 mg/kg
SEX/DURATION : female 21-45 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - hepatobiliary system
Reproductive - Specific Developmental Abnormalities - endocrine system
Reproductive - Specific Developmental Abnormalities - urogenital system
REFERENCE :
LANCAO Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823-
Volume(issue)/page/year: 2,1021,1973

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Primate - monkey
DOSE : 1500 mg/kg
SEX/DURATION : female 21-45 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - physical
REFERENCE :
TXCYAC Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85,
Limerick, Ireland) V.1- 1973- Volume(issue)/page/year: 2,239,1974

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rabbit
DOSE : 260 mg/kg
SEX/DURATION : female 6-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
resorbed implants per total number of implants)
Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured
before birth)
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 16,33,1978

** MUTATION DATA **

TYPE OF TEST : Mutation in microorganisms
TEST SYSTEM : Bacteria - Salmonella typhimurium
DOSE/DURATION : 20 mg/L
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE
Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 158,45,1985

TYPE OF TEST : Mutation in microorganisms
TEST SYSTEM : Yeast - Saccharomyces cerevisiae
DOSE/DURATION : 1100 umol/L
REFERENCE :
ARTODN Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000
Berlin 33, Fed. Rep. Ger.) V.32- 1974- Volume(issue)/page/year:
60,192,1987

TYPE OF TEST : Gene conversion and mitotic recombination
TEST SYSTEM : Yeast - Saccharomyces cerevisiae
DOSE/DURATION : 1100 umol/L
REFERENCE :
ARTODN Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000
Berlin 33, Fed. Rep. Ger.) V.32- 1974- Volume(issue)/page/year:
60,192,1987

TYPE OF TEST : Sex chromosome loss and nondisjunction
TEST SYSTEM : Yeast - Saccharomyces cerevisiae
DOSE/DURATION : 100 mg/L
REFERENCE :
CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House,
Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980-
Volume(issue)/page/year: 5,447,1984

TYPE OF TEST : DNA adduct
TEST SYSTEM : Mammal - species unspecified Lymphocyte
DOSE/DURATION : 10 mg/L
REFERENCE :
CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House,
Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980-
Volume(issue)/page/year: 15,1911,1994

*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
Chloric acid, sodium salt, mixt. with urea 102340-92-1
Chloric acid, thallium(1+) salt 13453-30-0
Chloriertes camphenSUBSTANCE DEFINITION :Consists of a mixture of chlorinated camphene with 67-69% chlorineREFERENCE :85GYAV "Pflanzenschutz-und Schaedlingsbekaempfungsmittel: Abriss einerToxikologie und Therapie von Vergiftungen," 2nd ed., Klimmer, O.R.,Hattingen, Fed. Rep. Ger., Hundt-Verlag, 1971 Volume(issue)/page/year:-,50,1971 13453-30-0
Chlorinated poly(vinyl chloride), pyrolyzate 13453-30-0
5-beta-Card-20(22)-enolide,3-beta-((2,6-dideoxy-3,4-O-(1-phenylmethyl)propylidene)-beta-D- ribo-hexopyranosyl)-5,14-dihydroxy-19-oxo- 35811-18-8
Chlorinated trisodium phosphate 11084-85-8
Chlorine 7782-50-5
Chlorine fluoride 7790-91-2
Chlorine fluoride (ClF5) 13637-63-3
Chlorine oxide 10049-04-4
Chlorisofos 76774-73-7
Chlorite 14998-27-7
Chlorocarcin A, dihydrochloride, hydrate 14998-27-7
Chlorocarcin B 59493-95-7
Chloroform 67-66-3
Card-20(22)-enolide,3-((2,6-dideoxy-4-O-beta-D-xylopyranosyl-beta-D-ribo-hexopyranosyl)oxy)- 5,14-dihydroxy-19-oxo-,(3-beta,5-beta)- 630-65-9
Chloroparaffin XP-470 630-65-9
Chlorophyll 1406-65-1
Chloroprene rubber 1406-65-1
Chlorostatin 37246-59-6
Chlorosulfuric acid 7790-94-5
Chlorosulfuric acid, (2-chloroethyl) ester 13891-58-2
Chlorosulfuric acid, (2-fluoroethyl) ester 371-94-8
Chlorothricin, 2(A)-hydroxy-, (2(A)R)-, (9CI) 111810-18-5
Chlorous acid, silver(1+) salt 7783-91-7
Chocolate Brown FB 12236-46-3
Card-20(22)-enolide,3-((diethylaminoacetyl)oxy)-5,14-dihydroxy-19-oxo-,(3-beta,5-beta)- 63979-66-8
Choerospondias axillaris (roxb.) Burtt. et Hill,fruit extract 63979-66-8
Choji (Japanese)SUBSTANCE DEFINITION :Crude drug extract from Syzygium aromaticaREFERENCE :MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AEAmsterdam, Netherlands) V.1- 1964- 63979-66-8
Cholan-24-oic acid, 3,7-bis(sulfooxy)-, trisodiumsalt, (3-alpha,5-beta,7-beta)- 89232-83-7
5-beta-Cholan-24-oic acid, 3-alpha,7-alpha-dihydroxy- 474-25-9
5-beta-Cholan-24-oic acid, 3-alpha,7-beta-dihydroxy- 128-13-2
5-beta-Cholan-24-oic acid, 3-alpha,6-alpha-dihydroxy- 83-49-8
5-beta-Cholan-24-oic acid,3-alpha,12-alpha-dihydroxy- 83-44-3
5-beta-Cholan-24-oic acid,3-alpha,12-alpha-dihydroxy- compd. with acenaphthene 83-44-3
5-beta-Cholan-24-oic acid,3-alpha,12-alpha-dihydroxy-, compd. withcholanthrene, 3-methyl- 83-44-3
5-beta-Cholan-24-oic acid,3-alpha-12-alpha-dihydroxy-, compound withdibenz(a,h)anthracene 83-44-3
5-alpha-Card-20(22)-enolide, 3-alpha,14-dihydroxy- 466-08-0
5-beta-Cholan-24-oic acid,3-alpha,7-alpha-dihydroxy-, monosodium salt 2646-38-0
Cholan-24-oic acid, 3,7-dihydroxy-12-oxo-, sodiumsalt 2646-38-0
Cholan-24-oic acid, 3,12-dihydroxy-7-oxo-, sodiumsalt 2646-38-0
Cholan-24-oic acid, 7,12-dihydroxy-3-oxo-, sodiumsalt 2646-38-0
5-beta-Cholan-24-oic acid,3-alpha,6-alpha-dihydroxy-, sodium salt 31687-62-4
5-beta-Cholan-24-oic acid,3-alpha,12-alpha-dihydroxy-, sodium salt 302-95-4
5-beta-Cholan-24-oic acid, 3,12-dioxo- 2958-05-6
Cholan-24-oic acid, 3,7-dioxo-12-hydroxy-, sodiumsalt 2958-05-6
Cholan-24-oic acid, 3,12-dioxo-7-hydroxy-, sodiumsalt 2958-05-6
Cholan-24-oic acid, 7,12-dioxo-3-hydroxy-, sodiumsalt 2958-05-6
5-beta-Card-20(22)-enolide, 3-alpha,14-dihydroxy- 545-52-8
5-beta-Cholan-24-oic acid, 3,6-dioxo-, sodium salt 545-52-8

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net